ProvexCV
Natural health product licensed in Canada
- Licence holder
- Melaleuca of Canada Inc.
- NPN or DIN-HM
- 80100445
- Status
- Active licence
- Licence date
- 20 May 2020
- Revision date
- 12 May 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 3.685 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 5.5 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 80-130:1 Dry plant equivalent : 20-32.5 mg Potency : 36 % Anthocyanins | 0.25 mg | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 12 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 95 % Polyphenols | Not specified | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 5.5 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 10-15:1 Dry plant equivalent : 630-945 mg Potency : 80 % Oligomeric proanthocyanidins | 63 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 165 Unités de papaïne du FCC | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 12.5 mg Potency : 6 % Terpene lactones | 0.25 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Cellulose microcristalline, Maltodextrine, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
- Source of antioxidant(s)/Provides antioxidant(s). - Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. - (Provides) An antioxidant. - Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. - Digestive enzyme. - Digestive aid. - Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
- Do not use this product if you are taking health products that affect blood coagulation as this may increase the risk of spontaneous bleeding.
- Précautions et mises en garde
- Consult a health care practitioner prior to use if you are pregnant or breastfeeding. - Consult a health care practitioner prior to use if you are pregnant or breastfeeding, or have a liver disorder or an iron deficiency. - Consult a health care practitioner prior to use if you are pregnant, breastfeeding, have gastrointestinal lesions/ulcers or are having surgery. - Consult a health care practitioner prior to use if you are taking anticoagulant/blood thinner or anti- inflammatory medications. - Consult a health care practitioner prior to use if you are pregnant, breastfeeding, have gastrointestinal lesion/ulcer or are having surgery. - Consult a health care practitioner prior to use if you are taking anticoagulant agents, anti-inflammatory agents or antibiotics. - Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure or seizures. - Consult a health care practitioner prior to use if you are taking prescription medications as resveratrol may alter the effectiveness of these medications. - Consult a health care practitioner if symptoms worsen. - Stop use and consult a health care practitioner if you develop symptoms of liver trouble such as yellowing of the skin/ eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/ or loss of appetite.
- Effets indésirables connus
- Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported. - Stop use if hypersensitivity/allergy occurs. - Stop use if hypersensitivity/allergy, nausea, vomiting or diarrhoea occurs.
Source
Official Health Canada record, licence 80100445
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging